|
HS Code |
144162 |
As an accredited N-(2'-Cyanobiphenyl-4-ylmethyl)-L-valine Methyl Ester Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
|
Purity 98%: N-(2'-Cyanobiphenyl-4-ylmethyl)-L-valine Methyl Ester Hydrochloride with purity 98% is used in pharmaceutical synthesis workflows, where it ensures consistent yield and reproducibility in active compound formation. Melting Point 156°C: N-(2'-Cyanobiphenyl-4-ylmethyl)-L-valine Methyl Ester Hydrochloride with a melting point of 156°C is used in high-temperature solid-phase peptide synthesis, where it maintains structural integrity under reaction conditions. Stability Temperature 40°C: N-(2'-Cyanobiphenyl-4-ylmethyl)-L-valine Methyl Ester Hydrochloride with stability at 40°C is used in long-term storage protocols, where it preserves compound activity and minimizes degradation. Molecular Weight 336.82 g/mol: N-(2'-Cyanobiphenyl-4-ylmethyl)-L-valine Methyl Ester Hydrochloride with a molecular weight of 336.82 g/mol is used in targeted drug design applications, where precise mass allows accurate dosage formulations. Particle Size ≤10 µm: N-(2'-Cyanobiphenyl-4-ylmethyl)-L-valine Methyl Ester Hydrochloride with a particle size of ≤10 µm is used in microencapsulation techniques, where fine dispersion enhances bioavailability and controlled release. |
Competitive N-(2'-Cyanobiphenyl-4-ylmethyl)-L-valine Methyl Ester Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In the evolving world of pharmaceutical research and organic synthesis, chemists always look for compounds that give both high purity and consistency, streamlining complicated multi-step reactions. N-(2'-Cyanobiphenyl-4-ylmethyl)-L-valine Methyl Ester Hydrochloride stands out as a practical tool in this space, appreciated for how it integrates into custom peptide synthesis and advanced intermediate creation. Research labs often develop custom molecules on tight timelines, so reliability and predictable quality matter just as much as technical specifications.
N-(2'-Cyanobiphenyl-4-ylmethyl)-L-valine methyl ester hydrochloride comes from a family of biphenyl derivatives that have become common in medicinal chemistry circles, thanks to their robust stability and useful reactivity. In my own graduate work, I ran into bottlenecks when custom peptide building blocks would break down or introduce isomeric confusion. Small changes in a molecule’s side chain—like using an L-valine methyl ester—make a surprising difference in solubility and handling, sidestepping some of the pain points that slow down multi-week syntheses.
The biphenyl backbone is no coincidence; many well-known antihypertensives and enzyme blockers share this motif. The nitrile substituent at the 2’-position nudges reactivity, giving this compound a distinct behavior compared to analogs lacking the cyano group. It’s not just a detail for reaction schemes; experienced chemists notice that certain nitrile-containing precursors allow for smoother downstream coupling reactions, especially when forming new C–N or C–C bonds under mild conditions.
Purity levels for this compound typically surpass 98%, with trace metal and water content kept in check—this isn’t the place to cut corners if you hope for consistent yields or reproducibility. The hydrochloride salt format improves shelf-stability and makes the solid easy to weigh, reducing the headaches that come with handling hygroscopic intermediates. From what I’ve seen in shared research settings, the salt form also minimizes static—no more losing precious milligrams to a spatula during transfers.
The methyl ester of valine—the protected amino acid fragment—prevents premature hydrolysis and racemization. In heated or high-pH environments, such protections can be the difference between a clean product and a streaky mess on a TLC plate. For those scaling up, quality control matters more than ever. Instead of rolling the dice with an unknown provider, many chemists have turned to vetting suppliers for consistent batches that meet published analytical standards (NMR, HPLC, mass spectra), and this product has developed a solid reputation in that world.
Drug discovery labs often use this molecule as a chiral intermediate for the development of angiotensin receptor blockers (ARBs), especially those built on a biphenyl scaffold. The biological relevance stems from the compound’s mimicry of structural motifs found in established pharmaceuticals, making it a natural fit in medicinal chemistry campaigns. By using an L-valine methyl ester unit, the compound introduces a chiral center that opens the door for enantioselective applications—critical when small differences in stereochemistry can translate into big differences in bioactivity.
Beyond drug scaffolding, the compound sees frequent use in the assembly of peptidomimetics and modified peptide chains. Its structure allows for strategic coupling strategies, such as amidation, sulfonation, or ring closures, that would be trickier with less protected amino derivatives. In my own experiments, switching to this building block often trimmed a purification step or helped dodge unwanted side reactions, letting me reclaim hours of bench time every week.
Process chemists appreciate reliable intermediates like this in pilot-scale production of test libraries, where time and material waste drive up costs fast. Because the compound resists hydrolysis and can be cleanly deprotected only when needed, scale-up moves faster, and downstream purification gets easier. Whether in a university lab or at a CRO, every chemist likes to avoid unnecessary troubleshooting, and the right starting materials make a real difference.
What really distinguishes N-(2'-Cyanobiphenyl-4-ylmethyl)-L-valine methyl ester hydrochloride from other protected amino acids or biphenyl intermediates stems from its carefully balanced design. While it may be tempting to compare it mainly to Fmoc- or Boc-protected valine, those versions don’t pair directly to the biphenyl core, often forcing extra steps with potentially messy protecting group swaps. The direct connection of the biphenyl unit to the amino acid not only streamlines synthetic routes but also adds functional value in custom ligand design and small-molecule libraries, where subtle modifications can make or break early lead compounds.
Biphenyl intermediates without a nitrile group limit versatility. The presence of the cyano moiety allows access to more advanced chemical transformations, such as palladium-catalyzed cross-coupling or selective functionalizations. In my group’s hands, we’ve used this nitrile to create a library of analogues with targeted polar surface area adjustments, all while keeping synthetic complexity under control.
Ordinary methyl esters of amino acids don’t bring enough muscle for highly specialized custom synthesis. Without the biphenyl linkage, they rarely serve as effective models or starting points for targeted pharmacophores, especially those mimicking ARBs or related therapeutic classes. This product, by combining the benefits of chiral L-valine, a robust biphenyl skeleton, and the practical methyl ester protection, gives molecular designers a way to move from concept to compound with fewer reruns and less risk of introducing off-target reactivity.
Anyone who has worked with a wide spectrum of protected amino acids knows the frustration of residue sticking to glassware, slow dissolution in standard solvents, and need for repeated recrystallization. This hydrochloride salt sidesteps those pain points. It dissolves nicely in popular organic solvents—acetonitrile, methanol, dichloromethane—striking a balance between solubility for reactions and easy isolation after workup.
In chromatographic separations, the compound tends to behave with predictable Rf values on both normal and reverse-phase TLC, which helps with fast method development and purification. Techs and students alike notice fewer unknown by-products or degradation issues, making it a reliable piece of the workflow puzzle. Get to the final compound faster, use less time and solvent—those advantages matter a lot once the novelty of a new synthesis fades and repetition sets in.
Analytical traceability presents another major plus. Each batch arrives with NMR, HPLC, and MS data, matching the expected profiles. No surprises in the spectra, no confusion about unintended regioisomers, just clean, verifiable data. Over time, this confidence boosts the productivity of a synthetic team—the human factor can be just as valuable as the technical one.
Academic and corporate researchers alike target efficiency and traceable workflows, so they need a building block that won’t introduce avoidable problems or hidden impurities. The model we’re discussing fits those demands, thanks to its well-characterized nature and consistent analytical profile across batches. Recent research on biphenyl ARBs and other small-molecule drugs has often traced unexpected activity back to slight differences in intermediate quality, highlighting why using a reliable starting material cuts downstream troubleshooting.
Its robustness, both in storage and reactivity, means that even in multi-month projects or long-term library construction, the batch-to-batch consistency isn’t just a marketing promise. From coordinating group efforts to training new chemists, it’s a relief to work with a compound that doesn’t need constant adjustment of protocols or unexpected changeovers to accommodate a finicky intermediate.
The medicinal chemistry landscape keeps shifting, with more labs seeking out modular synthetic tools that speed up hit-to-lead and lead optimization phases. As the pipeline from discovery to patient gets more competitive, having a defined, well-characterized intermediate like N-(2'-Cyanobiphenyl-4-ylmethyl)-L-valine methyl ester hydrochloride gives teams a head start. Multiple published syntheses have followed routes using similar compounds, and their reproducibility often comes down to starting materials.
As drug design trends expand into peptidomimetics and hybrid small-molecule approaches, demand for multi-functional intermediates keeps rising. High-purity, chiral building blocks paired with drug-like fragments let chemists cover more chemical space without restarting development from scratch. Students can focus on new reactions or target profiles, postdocs finish screening arrays faster, and production chemists know their scale-up process won’t get derailed by new impurities.
Peer-reviewed studies and community feedback repeatedly suggest that the reliability of protected biphenyl amino acid intermediates predicts both synthesis efficiency and the bioactivity landscape of resultant libraries. Unlike commodity amino esters, this compound’s combination of protected amino acid and biphenyl skeleton lets innovators chase new targets in areas ranging from cardiovascular drugs to enzyme inhibitors.
In talking with colleagues, I’ve often heard requests for custom analogs and new derivatives expanding on the basic N-(2'-Cyanobiphenyl-4-ylmethyl)-L-valine methyl ester motif. Chemists seek more handles for late-stage functionalization, such as alternate substituents on the biphenyl core or new side chains to tune solubility and targeting. Some look for isotopically labeled versions for tracer studies, others for more environmentally friendly synthetic procedures, reflecting the growing push for green chemistry standards.
Better supply chain transparency remains an ongoing concern in the fine chemicals industry. Analytical traceability and reliable lot documentation assure users they aren’t introducing variable unknowns at early synthetic steps. For material scientists and pharmaceutical developers, this reliability can compress the development timeline by skipping unnecessary repeat analysis, freeing up resources for high-value discovery efforts.
Research teams worldwide now lean into advanced analytical tools, such as LC-MS/MS, multidimensional NMR, and automated purification systems. Only well-behaved intermediates like this compound can extract the full value from such instruments, because undetected mixtures or impurities can throw off experiments and slow down innovation.
Best results come by storing the compound in dry, inert conditions, as with most protected amino acid intermediates. Desiccant-packed, amber glass minimizes degradation and combines with the hydrochloride format to further limit hydrolysis. Standard prepping techniques—dry box weighing, solution transfer with syringes—let even novice chemists achieve reproducible quantities and reactions.
Method optimization also draws out the advantages this compound offers. Adjusting pH and temperature, using high-purity solvents, and carefully matching scale to available purification capacity let both small and large batches yield ideal results. Peer support, literature searching, and supplier input help tailor protocols to unique targets while keeping learning curves short.
No two labs operate with identical resources, but building in an intentional selection of intermediates that reduce bottlenecks and handling risks lets operations stay nimble. Whether in university settings, fast-paced biotechs, or more traditional pilot plants, this compound has earned its place among the preferred toolkit components for reliable, high-quality peptide and small molecule assembly.
With the increase in expectation for both quality and speed in chemical research, not all intermediates can handle the real-world demands of daily lab work. This product, thanks to its carefully designed structure and traces of thoughtful feedback from the bench, has become a staple for those aiming to combine high-impact science with practical workflow management.
Its advantages—high purity, solid protection strategy, user-friendly salt form, and proven performance in advanced pharmaceutical campaigns—give chemists a rare sense of security in a business full of uncertainty. Drawing from hands-on lab time, I can say that the peace of mind and efficiency this compound delivers outweigh the incremental cost, while helping more scientific teams translate their smartest ideas into tangible progress.
Choosing N-(2'-Cyanobiphenyl-4-ylmethyl)-L-valine methyl ester hydrochloride fuels faster results, reduces risk, and unlocks new synthetic strategies. At a time when reproducibility and smart design count more than ever, an investment in reliable intermediates is an investment in better science and better outcomes.